Sabby Management’s Cyclo Therapeutics, Inc. Warrant CYTHW Stock Holding History

Sabby Management’s Portfolio CYTHW Stock Details CYTHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-193,012	Closed	-$208K	–	195
2020 Q4	$208K	Buy	+193,012	New	+$238K	0.04%	85

Other funds holding CYTHW

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sabby Management's CYTHW Position: Q1 2021 in Review

Sabby Management sold out of Cyclo Therapeutics, Inc. Warrant (CYTHW) in Q1 2021, closing a stake of 193,012 shares — an estimated $208K sold.

Sabby Management first reported a position in CYTHW in Q4 2020 and held it in 1 quarter. The position peaked at $208K in Q4 2020. 2 funds tracked by Wall St. Rank hold CYTHW as of Q1 2021.

Sabby Management reported no remaining Cyclo Therapeutics, Inc. Warrant position as of Q1 2021 after selling out during the quarter.
Sabby Management sold 193,012 Cyclo Therapeutics, Inc. Warrant shares in Q1 2021, an estimated $208K.
Sabby Management first reported a position in Cyclo Therapeutics, Inc. Warrant in Q4 2020 and held it in 1 quarter.
Sabby Management's Cyclo Therapeutics, Inc. Warrant position peaked at $208K in Q4 2020.
2 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Warrant as of Q1 2021.

Based on Sabby Management's 13F filing for Q1 2021, filed 17 May 2021.